You're reading the free version. Trader adds the live tape and alerts.
Start tracking
JAZZ Sale Disclosure
Gala Renee D · SEC Form 4 · Filed Nov 5, 2026
Sale
Calculated transaction value
$225.37K
Gala Renee D President & CEO
JAZZ
Jazz Pharmaceuticals
JAZZ
Transaction date
Nov 3, 2026
Public filing date
Nov 5, 2026
Filing lag
Filed 2 days later
JAZZ daily price context
Close on/before transaction
$229.74
Nov 3, 2026
First close after public filing
$234.76
Nov 6, 2026
Return after filing · so far
+5.72%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 1,000 shares @ $225.37
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001607737-26-000018
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$225.37K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Jazz Pharmaceuticals Plc JAZZ Current | Sale | Nov 3, 2026 | $225.37K |